Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interleukin Genetics

This article was originally published in The Tan Sheet

Executive Summary

Waltham, Mass.-based biotech company has signed letter of intent with "undisclosed major consumer products company" to market genomics-based nutritional and skin-care products, firm announces Sept. 3. Interleukin "uses functional genomics to develop diagnostic, therapeutic and nutraceutical products based on the genetic variations in people to help prevent or treat diseases of inflammation." A partnered study with Kaiser Permanente on diabetic patients' genetic risk for heart disease will be released this fall, may lead to diagnostic products, firm adds...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094507

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel